Clinical Trial Update: Effects of Metyrapone in Patients With Endogenous Cushing's Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial assessing metyrapone in patients with endogenous Cushing's syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Syndrome

Drugs mentioned

• Metyrapone (Metyrapone)

Snippet

Sponsor: HRA Pharma | Conditions: Cushing's Syndrome | Phase 3 | Status: COMPLETED